Retrieved medical literature supports the classification of drug toxicity, hypoxia, infectious toxic states, and malignancy-associated shifts as conditions linked to or driving acquired metabolic abnormalities.
The provided papers collectively discuss how hypoxia, malignancies, and drug toxicities intersect with systemic or cellular metabolic reprogramming and are frequently grouped under acquired metabolic and toxic conditions in clinical practice.